These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 820624)

  • 1. Estrogen-induced tetany in idiopathic hypoparathyroidism.
    Burckhardt P; Ruedi B; Felber JP
    Horm Res; 1975; 6(5-6):321-8. PubMed ID: 820624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoparathyroidism and the Kidney.
    Peacock M
    Endocrinol Metab Clin North Am; 2018 Dec; 47(4):839-853. PubMed ID: 30390817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid response to EDTA in hypoparathyroidism and in tetany.
    Burckhardt P; Tscholl-Ducommun J; Ruedi B
    Acta Endocrinol (Copenh); 1980 Jul; 94(3):346-53. PubMed ID: 6775488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oestrogen-induced hypocalcaemia in hypoparathyroidism.
    Nagant de Deuxchaisnes C
    Br Med J; 1979 Jun; 1(6177):1563-4. PubMed ID: 466121
    [No Abstract]   [Full Text] [Related]  

  • 5. Steroid-induced hypocalcaemia with tetany in a patient with hypoparathyroidism.
    Oikonomou D; Laina A; Xydaki A; Christopoulos C
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25406219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal parathyroid hormone levels do not exclude permanent hypoparathyroidism after thyroidectomy.
    Promberger R; Ott J; Kober F; Karik M; Freissmuth M; Hermann M
    Thyroid; 2011 Feb; 21(2):145-50. PubMed ID: 21190447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the effects of oestradiol, progesterone and some steroidal contraceptives on the adrenal cortex of albino rats.
    Zaki K; Sami GE; Wassef SA; Nour H; Hassan AA
    Egypt Popul Fam Plann Rev; 1973 Jun; 6(1):33-50. PubMed ID: 12257875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Parathyroid response to EDTA: effect of the immune heterogeneity of the parathyroid hormone].
    Burckhardt P; Boillat AM; Ruedi B; Felber JP; Courvoisier B
    Schweiz Med Wochenschr; 1975 Dec; 105(50):1692-5. PubMed ID: 814617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
    Lemay A; Dewailly SD; Grenier R; Huard J
    J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoparathyroidism.
    Al-Azem H; Khan AA
    Best Pract Res Clin Endocrinol Metab; 2012 Aug; 26(4):517-22. PubMed ID: 22863393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary estrogen and serum gonadotropin profiles in women ingesting oral contraceptive steroid formulations with variable estrogen content.
    Grimes EM; Thompson IE; Taymor ME
    J Natl Med Assoc; 1983 Jun; 75(6):575-80. PubMed ID: 6410078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
    Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
    J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoparathyroidism after I-131 therapy with subsequent return of parathyroid function.
    Burch WM; Posillico JT
    J Clin Endocrinol Metab; 1983 Aug; 57(2):398-401. PubMed ID: 6863481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple arterial occlusions and hypertension probably caused by an oral contraceptive: a patient in whom the development of renovascular hypertension has been followed.
    Delin K; Aurell M; Claes G; Teger-Nilsson AC; Wallentin I
    Clin Nephrol; 1976 Oct; 6(4):453-7. PubMed ID: 788979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoparathyroidism and pseudohypoparathyroidism.
    Maeda SS; Fortes EM; Oliveira UM; Borba VC; Lazaretti-Castro M
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):664-73. PubMed ID: 17117292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human parathyroid hormone therapy (1-34) in an adult patient with a gain-of-function mutation in the calcium-sensing receptor-a case report.
    Gonzales MC; Lieb DC; Richardson DW; O'Brian JT; Aloi JA; Khardori RK
    Endocr Pract; 2013; 19(1):e24-8. PubMed ID: 23186954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Hypoparathyroidism: Present and Future.
    Bilezikian JP; Brandi ML; Cusano NE; Mannstadt M; Rejnmark L; Rizzoli R; Rubin MR; Winer KK; Liberman UA; Potts JT
    J Clin Endocrinol Metab; 2016 Jun; 101(6):2313-24. PubMed ID: 26938200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the combined steroidal contraceptives (Gynanovlar 21 and Lyndiol 2.5) on the human adrenocortical and ovarian activities.
    Zaki K; Kamal I; Talaat MM; Rashad S; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):41-65. PubMed ID: 12256027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypoparathyroidism: the present state of art].
    Krysiak R; Handzlik-Orlik G; Kedzia A; Machnik G; Okopień B
    Wiad Lek; 2013; 66(1):18-29. PubMed ID: 23905424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.